|
While the country debates the merits and concerns about Social Security
privatization, Medicare has been morphed into a set of private plans with little
attention or discussion. The private Medicare train is already out of the
station.
Medicare Privatization on a Fast Track
The movement to privatize Medicare began in the 1980s with
the introduction of Medicare managed care and has continued on this perilous
track ever since. In 1997 Medicare Part C introduced a variety of private plans
under the banner of “Medicare+Choice”. These private options, largely managed
care, thrived for a few years and then began to withdraw from Medicare as
government payments and plan profit margins diminished. The plan withdrawals
left many beneficiaries with no private options and with the insecurity of
“losing their Medicare”.
Most dramatically, the Medicare Modernization Act of 2003
began a major restructuring of the traditional Medicare program, relying
exclusively on private plans to deliver the new Part D prescription drug
coverage. The 2003 law and the Deficit Reduction Act of 2005 provide substantial
subsidies to private companies that offer Medicare plans in 2007. Private
Medicare options, now known as “Medicare Advantage,” (MA) plans will be paid
about 11% more per enrollee, or about $828, than Medicare would pay if the
enrollee remained in the traditional program. These payments will total about
$5.7 billion in 2007 and nearly $30 billion over the five years from 2007 -2011.[1]
The dire consequences that privatization has had, and will
have, on beneficiaries and taxpayers alike are documented in recent reports, two
of which are highlighted below. These reports also discuss the
Administration’s devotion to turning Medicare over to private industry – even
when privatization is less efficient, more costly, and may bring about the end
of Medicare as the successful social insurance program it has been since 1965.
In Medicare Privatization: Windfall for the Special
Interests, Families USA documents the excessive payments which Medicare makes to
private Medicare Advantage companies offering Part D plans (MA-PDs), and to
regional preferred provider organizations (PPOs), in order to keep them in the
market and to help move more beneficiaries into private plans. According
to the report, Medicare Advantage drug plans received an extra $4.6 billion over
what regular Prescription Drug Plans (PDPs) received in 2006. If this
continues over five years, they would be paid as much as $23.5 billion more than
PDPs and traditional Medicare to take care of the same beneficiaries. Congress,
in passing the MMA, also set aside $10 billion through 2013 to ensure access to
regional PPOs through higher payments, this on top of the payment available to
all MA plans. That is an extra $10 billion to ensure access to something that
88% of beneficiaries already have access to in 2006. It doesn’t appear
that additional payments are needed to keep regional PPOs in the market.
The Families’ Report indicates that the government’s
rationale for these overpayments is that the managed care system saves Medicare
money, despite higher upfront costs, by limiting the network of providers and
coordinating care. In actuality, according to the Report, MA plans usually
enroll healthier beneficiaries who do not mind a limited network of providers,
and cost the system less overall, resulting in overpayments when compared to
traditional Medicare.
Managed care enrollment grew through the 1990s but declined
after 1999, resulting in plans withdrawing from the market. When market forces
on their own actually pushed private managed care plans out, Medicare offered
further overpayments to keep plans in the market in an effort to lure more
beneficiaries into private managed care.
Despite government efforts to push beneficiaries into private
plans, almost 90% have chosen to remain in traditional Medicare. But this
preference is at an ever-increasing cost for beneficiaries and taxpayers. As
healthier beneficiaries move to private plans, beneficiaries enrolled in
traditional Medicare are needier and premiums in the traditional program
increase because the mix of beneficiaries is sicker and older. The increased
costs for traditional Medicare also affect taxpayers, since general revenues
cover most of the costs of Medicare. Meanwhile beneficiaries and taxpayers are
also paying for subsidies to private plans and for the unnecessarily high prices
for drugs under Part D resulting from the law’s prohibition on Medicare
negotiating prices with the pharmaceutical industry.
A second report, released by Congressman Henry Waxman in a
letter to Michael Leavitt, Secretary of the US Department of Health and Human
Services (HHS), demonstrates that Medicare beneficiaries have not benefited from
the Part D privatized prescription drug system. The letter was written in
response to statements made to the contrary by the Centers for Medicare &
Medicaid Services (CMS), the HHS agency responsible for Medicare.
Specifically, CMS claimed that 83% of beneficiaries would
have access to Part D plans with lower premiums in 2007 than they paid in 2006.
According to the Waxman study, the CMS analysis erroneously accounts for
premiums in MA-PD plans, as well as stand alone PDPs. Since MA-PD plans charge a
single premium for a package of services, covered by Medicare Parts A, B and D
in the traditional program, one can only surmise what part of the MA-PD’s
premium is actually for Part D. Only one quarter of beneficiaries enrolled in
Part D in 2006 elected an MA-PD. The other 75% are in a stand alone PDP and
traditional Medicare. The Waxman study found that for these people, the vast
majority of Medicare beneficiaries, Part D premiums will actually increase for
beneficiaries as follows:
-
Across all drug plans (PDPs), premiums will
increase an average of 13.2% in 2007
-
For PDPs with the same deductible and same
donut hole coverage in 2006 and 2007, premiums will increase
11.1% in 2007,
-
For the lowest priced PDPs, premiums will
increase by 44% for 2007
Including MA-PD premiums in the estimate for the average
national premium artificially lowers the premium amount, and misleads Medicare
beneficiaries about the true cost of their drug options. Because, as
described above, MA-PDs are heavily subsidized by the government, they sometimes
offer lower premiums, (although they may also offer more limited providers and
coverage). The lower premiums are steering more beneficiaries into private
health plans, rather than keeping them in traditional Medicare.
Consequences Down The Line
This unnecessary spending to keep private plans in Medicare
is costly to beneficiaries and taxpayers and has even more serious implications
for the future. Overpayments and higher premiums in private plans are raising
the overall cost of the Medicare program. Meanwhile, a little known provision of
the 2003 MMA law established a rule that if two consecutive Medicare Trustees’
Reports estimate that more than 45% of Medicare’s budget within the next six
years will come from general revenues, the President must propose legislation to
lower the cost to less than 45%. The most recent Trustees’ report
estimated that the 45% mark would be reached in 2012, and it is likely that the
next report will include a similar estimate. If this happens, Medicare will be
subject to draconian cuts and more privatization. This is ironic, since
privatization is substantially responsible for the increasing cost of Medicare.
While the country has, so far, successfully resisted
privatizing Social Security, Medicare has already been transformed into an array
of private plans, with barely any comment from the media or policy makers. We
are already hearing that we can't afford this old Medicare program and must,
cynically, look more, not less, to limited-coverage from private plans.
Meanwhile people with Medicare - soon to include millions of Baby Boomers - will
have to go without. And insurance, managed care, and pharmaceutical
companies will benefit.
It is time to stop egregious overpayments to private industry
and start promoting and developing the affordable, comprehensive traditional
Medicare program. We need to flag down the private Medicare train that’s
speeding down the track before it’s too late.
[1] Brian Biles, MD, Payments to Medicare Advantage Plans Exceed
Fee-For-Service Costs: Options for Medicare Savings from 2007 – 2011,
(George Washington University, 9/15/2006).
|